Font Size:
a
A
A
Keyword [alProstadil]
Result: 21 - 40 | Page: 2 of 6
21.
The Early Studies Of Alprostadil For Its Curative Effect On Postoperative Of Congenital Heart Disease Combined Pulmonary Hypertention
22.
The Alprostadil Injection Of Connective Tissue Disease Due To Raynaud’s Phenomenon In Patients With Serum ET-1, NO, NOS And INOS Levels
23.
Effect Of Alprostadil On The Nail-fold Microcirculation In Patient With Raynaud’s Phenomenon Induced By Connective Tissue Disease
24.
The Changes Of Oxidative Stress And Inflammatory Factors And Impact Of Alprostadil Injection Therapyin In Diabetic Lower Extremity Arterial Disease
25.
The Effect Of Alprostadil Injection On The Expressions Of Angiopoietin2and IL-18in Streptozotocin-induced Diabetic Mice
26.
The Expression Of VEGF In Glomerular Endothelial Cells Cultured In High Glucose Ambient And The Regulation Of Alprostadil
27.
Research Alprostadil Injection Intervention Of Atherosclerosis Sclerosis Rat Model
28.
Basic Research On The Injury Of Brains About Fluoroacetamide Poisoning Rats And The Medication
29.
The Protective Effect And Potential Mechanisms Of Alprostadil Injection On No-reflow Phenomenon After Myocardial Ischemia-reperfusion In Rats
30.
The Effect Of Alprostadil Postconditioning On Toll-like Receptor4Expression In Dogs With Hemorrhagic Shock Induced Lung Injury
31.
Efficacy Of Terlipressin Combined Alprostadil Treatment Of Liver Cirrhosis With Refractory Ascites
32.
The Study Of Alprostadil In Prevention Of Contrast Induced Nephropathy In Diabetic Patients After Percutaneous Coronary Intervention
33.
The Effect On The Cardio-pulmonary Function Of The Patients After Coronary Artery Bypass Graft By Using Alprostadil
34.
Studies On Solid Lipid Nanoparticles Loaded With Alprostadil
35.
Protective Effect Of Acetamide Combined With Alprostadil Injection On Myocardium Of Rats Of Fluoroacetamide Poisoning
36.
Protective Effect And Mechanism Of Alprostadil Injection On Contrast-induced Nephropathy In Rats
37.
The Renal Protective Effect Of Alprostadil Combined With Hydration Treatment On Diabetic Nephropathy Patients After PCI
38.
Impacts Of Alprostadil On Myocardial Microcirculation In Patients With Non-ST-Segment Elevation Coronary Myocardial Infarction Receiving Percutaneous Coronary Intervention
39.
Clinical Observation Of Alprostadil In Treating Benign Arteriolar Nephrosclerosis Caused By Elderly Hypertension
40.
Observation Of Alprostadil Combined With Propranolol In Patients With Cirrhosis And Portal Hypertension
<<First
<Prev
Next>
Last>>
Jump to